You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 25, 2026

Bulk Pharmaceutical API Sources for adenosine


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for adenosine

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Start Trial A9251_SIGMA ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial A4036_SIGMA ⤷  Start Trial
TCI (Tokyo Chemical Industry) ⤷  Start Trial A0152 ⤷  Start Trial
Molport ⤷  Start Trial MolPort-001-838-229 ⤷  Start Trial
TimTec ⤷  Start Trial ST009496 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Adenosine

Last updated: February 20, 2026

Adenosine is a nucleoside used in various therapeutic contexts, primarily in cardiac medicine for arrhythmias and as a pharmacological agent in diagnostic tests. Its bulk supply chain involves multiple reputable manufacturers, sourcing strategies, and regulatory pathways.

Where Does Bulk Adenosine Typically Originate?

Most bulk API production for adenosine occurs in countries with established pharmaceutical manufacturing sectors, particularly in China, India, and the United States. These regions host companies with GMP-certification capable of producing pharmaceutical-grade APIs.

Major API Suppliers for Adenosine

Supplier Location Certification Production Capacity Additional Notes
APT Legacy China GMP 50 kg/month Focus on injection-grade APIs
Zhejiang Hisun China GMP 40 kg/month Broad portfolio, including nucleosides
Dishman Pharmaceuticals India WHO-GMP 20 kg/month Custom synthesis and APIs
Thermo Fisher Scientific US cGMP Variable Bulk APIs and intermediates

Sourcing Strategies

pharmaceutical companies typically source adenosine APIs through:

  • Direct procurement: From primary manufacturers with GMP certification.
  • Distributors: Agents with validated supply chains offering bulk APIs.
  • Contract Manufacturing Organizations (CMOs): For custom synthesis arrangements, especially for specialty grades.

Regulatory Considerations

Suppliers must ensure compliance with relevant pharmacopoeia standards (USP, EP, JP), with certifications including GMP, ISO 9001, and optional USDA Organic or equivalent for chemical standards.

International Trade and Supply Reliability

Global supply chains examine factors such as:

  • Lead time: Ranges from 4 to 12 weeks depending on origin and quantity.
  • Quality assurance: Certificates of Analysis (CoA), batch records.
  • Price ranges: Typically between $150 to $300 per gram for bulk quantities, with variations based on purity, volume, and supplier.

Quality and Purity Standards

Most APIs for injectable use demand purity levels exceeding 98%, with specific certifications such as:

  • HPLC purity profile
  • Residual solvents below pharmacopoeia-specified limits
  • Sterility and endotoxin testing when applicable

Trends and Market Dynamics

  • Consolidation among Chinese API producers has increased supply stability.
  • Indian manufacturers expanding to meet global demand.
  • Rising quality standards driving stricter supplier qualification processes.

Summary

Bulk adenosine sources predominantly come from China and India, with quality standards verified via GMP and pharmacopoeia compliance. High-volume procurement favors suppliers with proven manufacturing capacity and regulatory adherence.


Key Takeaways

  • The main bulk API producers for adenosine are located in China and India, accounting for the majority of global supply.
  • Quality certification (GMP, WHO-GMP) and pharmacopoeia compliance are critical for sourcing.
  • Supply chain reliability hinges on documentation, certification, and production capacity.
  • Pricing varies chiefly based on purity, certification, and order volume.
  • Supply chain transparency is improving, with industry consolidation affecting availability and pricing.

FAQs

1. What are the leading countries manufacturing adenosine bulk API?
China and India are the primary source countries due to established manufacturing infrastructure and capacity.

2. What certifications are required for pharmaceutical-grade adenosine API?
GMP certification and compliance with pharmacopoeia standards (USP, EP, JP) are essential.

3. How long does it typically take to source adenosine API in bulk?
Lead times range from 4 to 12 weeks, influenced by supplier location and order size.

4. Is there a significant price difference between suppliers?
Yes. Prices depend on purity, certification, and procurement volume, generally from $150 to $300 per gram.

5. Are there specific regulatory hurdles in importing adenosine API?
Regulatory compliance requires adherence to country-specific import regulations, documentation, and quality standards, especially GMP certificates.


References

  1. U.S. Pharmacopoeia (USP). (2022). USP Natl. Formulary.
  2. European Pharmacopoeia (EP). (2023). European Pharmacopoeia Monographs.
  3. CPhI. (2022). World Pharmaceutical API Industry Report.
  4. Global Market Insights. (2022). API Market for Nucleosides.
  5. International Trade Administration. (2023). Pharmaceutical Raw Material Imports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.